Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TRAW
$0.57
-4.83%
TRAW · Traws Pharma, Inc.
$0.57
-0.03 (-4.83%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern through the one-year period after the date that the financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.78M
Shares
15.37M
All earnings calls
Earnings call · FY2022 Q4
Traws Pharma, Inc. Q4 FY2022 Earnings Call
Traws Pharma, Inc. Q4 FY2022 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$56,000
+0% YoY
Net income · derived Q4
-$5.42M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 16, 2023 · complete as-filed document
SEC periodic report
10-K report
Filed May 1, 2023 · complete as-filed document